Novel insights of elevated systemic levels of bisphenol-A (BPA) linked to poor glycemic control, accelerated cellular senescence and insulin resistance in patients with type 2 diabetes.
Level 4 - case-series / case-control
Case-control observational study comparing patients with type 2 diabetes to normoglycemic controls
PubMed 31004310 · doi:10.1007/s11010-019-03540-9
What was done
Serum bisphenol-A (BPA) concentrations were measured by ELISA in Asian Indian adults with type 2 diabetes mellitus (T2DM, n = 30) and controls with normal glucose tolerance (n = 30). In peripheral blood mononuclear cells (PBMCs), investigators measured the expression of senescence markers (GLB1, p16, p21, p53), inflammatory markers (IL-6, TNF-α), estrogen-related receptor gamma (ERRγ), and telomere length.
What was found
The abstract does not provide exact numerical values, correlation coefficients, or p-values. It reports that serum BPA levels were significantly higher in patients with T2DM than in controls. Serum BPA positively correlated with insulin resistance, poor glycemic control, inflammatory markers (IL-6, TNF-α), senescence markers (GLB1, p16, p21, p53), and ERRγ expression, while negatively correlating with telomere length.
Why it matters
This study links environmental BPA exposure to PBMC cellular senescence, telomere shortening, and systemic inflammation in Asian Indian patients with type 2 diabetes, suggesting potential pathways for EDC-mediated metabolic disruption.
Limits
The sample size is very small (30 per group) and limited to a single ethnic group. The observational, cross-sectional design cannot establish causality. BPA was quantified via ELISA rather than mass spectrometry, and the abstract omits specific numerical concentrations, effect sizes, and statistical values.
Cited by
- supports Environmental chemicals in plastics such as BPA mimic estrogen in the human body.